期刊文献+

非索非那定大鼠体内药代动力学研究 被引量:1

Pharmacokinetic study of fexofenadine in rats
下载PDF
导出
摘要 目的建立高效液相色谱法(HPLC)研究非索非那定灌胃给药后非索非那定体内药动学特点。方法采用HPLC测定,色谱柱为DikmaTMC18(4.6mm×250mm,5μm),流动相:乙腈-0.5%磷酸二氢钾(pH3.8)-三乙胺(30∶70∶0.3),流速:1.2ml/min,检测波长:220nm,检测非索非那定大鼠灌胃后药代动力学参数。结果非索非那定的药动学模型为二室模型,其药动学参数为Ka=1.689h-1,Cmax=1.225μg/ml,Tmax=1.8h,MRT=5.013h,t1/2α=1.018h。结论高效液相色谱法研究非索非那定大鼠灌胃给药后体内药代动力学,方法预处理简单、专属性强,结果可靠。 Objective To develop a method for the determination of fexofenadine in rat plasma after a single oral administration. Methods The supernatant was injected directly on a DikmaTM C18 column (250mm × 4.6mm,51μm) with the mobile phase consisted of a mixture of acetonitrile-0.5% KH2PO4 buffer-triethylamine ( 30: 70:0.3 ) at a flow rate of 1.2mL/ min. The UV detection wavelength was 220nm. The pharmaeokinetie parameters of fexofenadine were recorded. Results After orally taken fexofenadine, the plasma concentration-time course in rats fitted well to 2-compartment model and with the following pharmaeokinetie parameters :Ka = 1. 689 h^-1,Cmax=1. 225μg/ml, Tmax= 1.8h,MRT=5. 013h,t1/aα = 1. 018h. Conclusion The HPLC method to determine plasma concentration of fexofenadine and pharamacokinetie parameters in rats is feasible.
出处 《临床合理用药杂志》 2009年第13期4-5,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 非索非那定 HPLC 药代动力学 大鼠 Fexofenadine HPLC Pharmaeokineties Rats
  • 相关文献

参考文献6

  • 1Tsukasa U,,Norio YF.Liquid chromatographic determination of fexofena-dine in human plasma with fluorescence detection[].Journal of Phar-ma-ceutical and Biomedical Analysis.2004
  • 2Stohz M,Arumugham T,Iippert C,et al.Effect of food on the bioavail-ability.of fexofenadine hydrochloride(MDL16455A)[].BiopharmDrug Dispos.1997
  • 3Markham A,Wagstaff AJ.Fexofenadine[].Drugs.1998
  • 4HofmannU,SeilerM,DrescherS,etal.Determinationof fexofenadineinhumanplasmaandurinebyliquidchromatogra phy massspectrometry[].JChromatogrB.2002
  • 5Russell T,Stoltz M,Weir S.Pharmacokinetics, pharmacody-namics, and tolerance of single-and multiple-dose fexofenadine hydrochloride in healthy male volunteers[].Clinical Pharmacology and Therapeutics.1998
  • 6T. Radhakrishna,G. Om Reddy.Simultaneous determination of fexofenadine and its related compounds by HPLC[].J Pharma and Biomed Analysis.2002

同被引文献9

  • 1陈晓玲.HPLC法测定犬血浆中非索非那定的浓度[J].实用医院临床杂志,2009,6(6):65-66. 被引量:4
  • 2Borade PS, Ballary CC ,Currie GP ,et al. Modern HI -antihistamines inasthma [ J ]. Drug Discove Today, 2006,3 ( 3 ) :253.
  • 3Sun J, Lu R, Fan XW, et al. The important roles of transporter protein in drug delivery[ J]. Chin Pharm J,2007,42 (3) :164.
  • 4Nirogi RV, Kandikere VN, Shukla M ,et aL Quantification of fexofena- dine in humanplasma by liquid chromatography coupled to electros-pray tandem mass spectrometry using mosapride as internal standard [ J ]. Biomed Chromatogr ,2007 ,21 ( 2 ) : 209 -216.
  • 5Fu I, Woolf E J, Matuszewski BK. Determination of fexofenadine in hu- man plasma using 96-well solid phase extraction and HPLC with tan-dem mass spectrometric detection [ J ]. Pharm Biomed Anal, 2004,35 (4) :837-846.
  • 6Bharathi VD, Radharani K, Jagadeesh B, et al. LC-MSIMS assay for simultaneous quantification of fexofenadine and pseudoephedrine inhuman plasma[ J ], Chromatographia ,2008,67:461-466.
  • 7刘茜,刘翠,尚宏伟,杨伦,王鹭.盐酸非索非那定胶囊药物动力学及人体相对生物利用度研究[J].药物分析杂志,2007,27(11):1707-1710. 被引量:6
  • 8徐海燕,张鹏,王学娅,高靥,申涛,赵怀清.高效液相色谱-荧光法测定人血浆中非索非那定[J].药物分析杂志,2008,28(1):61-64. 被引量:5
  • 9孙忠实.抗组胺药物的进展[J].中国新药杂志,1999,8(7):448-450. 被引量:34

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部